Chemical activators of Olr728 can engage various signaling pathways to initiate its activation. Forskolin directly activates adenylate cyclase, leading to an increase in cyclic AMP (cAMP) levels within the cell. This elevation in cAMP triggers protein kinase A (PKA) activation, which can phosphorylate and activate Olr728. Similarly, Isoproterenol acts on beta-adrenergic receptors, enhancing adenylate cyclase activity and cAMP accumulation, which in turn activates PKA and subsequently Olr728. Epinephrine, by stimulating both alpha and beta-adrenergic receptors, also causes an upsurge in adenylate cyclase activity and cAMP levels, leading to the activation of PKA, a kinase that can target and activate Olr728. Histamine, through interaction with H2 receptors, elevates adenylate cyclase activity, thus raising cAMP levels and activating PKA, which may phosphorylate and activate Olr728.
Further, Serotonin, by activating 5-HT receptors that are coupled to adenylate cyclase, causes an increase in cAMP and the activation of PKA, which can lead to the activation of Olr728. Dopamine, through D1-like receptors, and Adenosine, through A2 receptors, both enhance adenylate cyclase activity, thereby raising cAMP levels and activating PKA, thereby facilitating the activation of Olr728. Prostaglandin E2 engages EP2/EP4 receptors that activate adenylate cyclase, which in turn increases cAMP and activates PKA, potentially leading to Olr728 activation. Glucagon interacts with its receptor to produce a similar effect on adenylate cyclase and cAMP levels, thus activating PKA and Olr728. Caffeine and IBMX, as phosphodiesterase inhibitors, prevent the degradation of cAMP, thereby sustaining the activation of PKA, which is then able to activate Olr728. BAY 60-6583, by selectively activating adenosine A2B receptors, also contributes to the increase in adenylate cyclase activity and cAMP levels, which can lead to the activation of PKA and subsequent activation of Olr728. Each chemical, through its unique interaction with specific receptors or enzymes, ensures the upregulation of adenylate cyclase activity and cAMP levels, which are pivotal in the activation of PKA and the subsequent activation of Olr728.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Engages beta-adrenergic receptors, leading to the activation of adenylate cyclase and subsequent increase in cAMP levels. The activation of PKA by cAMP can then lead to the activation of Olr728. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Stimulates both alpha and beta-adrenergic receptors, causing adenylate cyclase activation, increase in cAMP, and activation of PKA, which may result in the activation of Olr728. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Through H2 receptors, increases adenylate cyclase activity, thereby raising cAMP levels and activating PKA, which in turn can activate Olr728. | ||||||
Serotonin hydrochloride | 153-98-0 | sc-201146 sc-201146A | 100 mg 1 g | $118.00 $187.00 | 15 | |
Activates 5-HT receptors that are coupled to adenylate cyclase, leading to increased cAMP and activation of PKA, potentially resulting in Olr728 activation. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
By binding to D1-like receptors, dopamine can increase adenylate cyclase activity, cAMP levels, and activate PKA, which could lead to Olr728 activation. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Activation of A2 receptors by adenosine leads to increased adenylate cyclase activity, raising cAMP levels and activating PKA, which could activate Olr728. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Binds to EP2/EP4 receptors, activating adenylate cyclase, increasing cAMP, and activating PKA to potentially activate Olr728. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
As a phosphodiesterase inhibitor, caffeine prevents the degradation of cAMP, sustaining PKA activation and potentially leading to Olr728 activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterases, leading to increased cAMP levels and sustained activation of PKA, which may result in Olr728 activation. | ||||||
BAY 60-6583 | 910487-58-0 | sc-503262 | 10 mg | $210.00 | ||
Selectively activates adenosine A2B receptors, which increases adenylate cyclase activity, cAMP levels, and could lead to the activation of PKA and subsequent activation of Olr728. | ||||||